Percutaneous Microwave ablation, Percutaneous Radiofrequency Ablation and Laparoscopic radiofrequency ablation and resection treatment for hepatocellular carcinoma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000550

Enrollment

Unknown

Registered

2009-10-10

Start date

2008-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer (hepatocellular carcinoma)

Interventions

LRFA group:Laparoscopic radiofrequency ablation treatment for HCC

PRFA group:Percutaneous radiofrequency ablation treatment for HCC

RES group:Conventional resection treatment for HCC

PMWA group:Percutaneous microwave ablation treatment for HCC

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. HCC patients without any treatment; 2. Single lesion diameter < 5 cm or tumor numbers < 3 and diameter < 5 cm; 3. Child-Pugh A or B; 4. Blood coagulation function normal.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactation period women; 2. Patient has received other treatment; 3. Portal vein and hepatic vein and IVC tumor thrombus; 4. Extrahepatic metastasis.

Design outcomes

Primary

Measure	Time frame
Survival rate;	—

Secondary

Measure	Time frame
Local recurrence rate;	—

Countries

China

Contacts

Public ContactPing Liang

liangping301@hotmail.com+86 66939530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026